drugset / Trial / NCT00260962

Olanzapine in the Treatment of Patients With Anorexia Nervosa

NCT00260962

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to evaluate the efficacy of an anti-psychotic medication, Olanzapine, in achieving desired weight gain in patients identified as having Anorexia Nervosa, either restricting or binge/purge subtype. The study will also evaluate the possible beneficial effects of Olanzapine in reducing the severity of the obsessive and/or anxiety symptoms associated with this disorder.

Timeline

Start
2000-09
Primary completion
2006-07
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Olanzapine Small molecule 10 mg

Indications